Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee hears House Bill 276 to protect 340B access for federally qualified health centers
Summary
House Bill 276 received a first hearing in the House Insurance Committee. Sponsors said the bill would bar drug manufacturers from restricting 340B drug distribution to covered entities and would establish state guidelines to ensure FQHCs can use 340B savings to support patient services.
The House Insurance Committee held a first hearing on House Bill 276, which sponsors said would protect participation by federally qualified health centers (FQHCs) in the federal 340B drug pricing program. Testimony said the measure would prohibit drug manufacturers from denying or restricting delivery of 340B drugs to covered entities or requiring claim-data submissions beyond what the U.S. Department of Health and Human Services requires.
Colonel Adam Holmes testified that the bill’s “focus is to help ensure that certain safety net providers eligible for reduced drug…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
